最近の新規医薬品の承認と予測 (2025年3Q~2026年2Q)

Matthew H Rim¹, Rachel Joseph², Lauren Endriukaitis¹

¹Northwestern Medicine, Chicago, IL, USA.

American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists

|August 29, 2025

まとめ

医療制度の薬剤師は新薬の承認に備えることができますこのレビューでは,来年中に患者ケアと病院資源に影響を及ぼすと予想される主要な治療法を強調しています.

科学分野:

医薬品科学
臨床薬局
薬物開発

背景:

医療制度の薬剤師は処方箋の管理と臨床プログラムの最適化に不可欠です
製薬パイプラインのモニタリングは資源配分と戦略的計画に不可欠です
新しい治療法は,処方箋の統合と臨床効果の積極的な評価を必要とします.

研究の目的:

医療制度の薬剤師に新しい薬の承認に関する最新の情報を提供する.
重要な臨床的および財政的な影響を及ぼす可能性のある新しい治療法を特定する.
薬剤師が医療施設に革新的な治療法を導入する準備を支援する.

主な方法:

米国食品医薬品局 (FDA) の承認を待っている新薬のレビュー.
分析は2025年第3四半期から2026年第2四半期に予想される治療法に焦点を当てた.
選考基準は,病院や診療所で重要な臨床的,財政的な影響を期待する薬剤を強調した.

主要な成果:

製薬パイプラインにはFDAの承認を待っている56の新薬が含まれています.
予期される承認は,希少および超希少疾患のための新しい治療法を含みます.
主要な分野には,標的型がん治療法と様々な疾患に対する新しい薬剤が含まれます.

結論:

新しい治療法が薬の開発パイプラインを絶えず強化しています
薬剤師は患者への最適なケアと資源管理を確実にするために薬剤の承認について常に情報を得なければなりません
薬剤パイプラインへの積極的な関与は,医療システムにおける薬局の実践にとって極めて重要です.

キーワード:

食品医薬品局による医薬品承認臨床試験薬の承認プロセス研究中の薬物薬の開発新しい薬の承認

さらに関連する動画

10:29

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Published on: May 9, 2025

1.5K

09:42

Comprehensive Analysis of Drug Response using the FLICK Assay

Published on: June 6, 2025

377

関連する概念動画

01:11

Clinical Trials: Overview

3.4K

Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...

3.4K

01:26

Drug Administration and Therapy Phases: Overview

738

Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...

738

01:25

Drug Regulation

1.8K

Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...

1.8K

01:06

Drug Clearance: Overview

161

Drug elimination refers to drug removal from the body, either through urine or bile, by the kidneys or liver, respectively. A pharmacokinetic parameter, drug clearance, measures the efficiency of drug removal from the bloodstream within a specific time frame. It is calculated as the rate at which a drug is eliminated from plasma divided by the drug's concentration in plasma.
Drug clearance is not limited to renal excretion but encompasses all organs involved in drug elimination, including...

161

01:02

Prescription, Nonprescription and Orphan Drugs

842

Prescription drugs require a prescription from a medical practitioner and can only be obtained from a pharmacy. They have many applications, including treating pain, anxiety, and hypertension.
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...

842

01:26

Drug Discovery: Overview

8.7K

Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...